Skip to main content
. 2019 Aug 8;4(8):13371–13381. doi: 10.1021/acsomega.9b01544

Figure 8.

Figure 8

MBs-RGD treatment (group 4M): white light (left) and fluorescence (right) visualization following MBs-RGD injection of (A) cranium, (B) chest cavity, (C) peritoneal cavity.